4//SEC Filing
Gilbert Mark John 4
Accession 0001493152-21-030884
CIK 0001857044other
Filed
Dec 7, 7:00 PM ET
Accepted
Dec 8, 9:58 PM ET
Size
5.3 KB
Accession
0001493152-21-030884
Insider Transaction Report
Form 4
Gilbert Mark John
Director
Transactions
- Award
Stock Option (right to buy)
2021-12-01+20,000→ 20,000 totalExercise: $5.35Exp: 2031-12-01→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]One hundred percent of the stock options vest and become exercisable on December 1, 2022.
Documents
Issuer
Indaptus Therapeutics, Inc.
CIK 0001857044
Entity typeother
Related Parties
1- filerCIK 0001897698
Filing Metadata
- Form type
- 4
- Filed
- Dec 7, 7:00 PM ET
- Accepted
- Dec 8, 9:58 PM ET
- Size
- 5.3 KB